Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication

The Journal of Biological Chemistry
Grant R CampbellStephen A Spector

Abstract

In this study, we investigated the effects of the dual phosphatidylinositol 3-kinase/mechanistic target of rapamycin (PI3K/MTOR) inhibitor dactolisib (NVP-BEZ235), the PI3K/MTOR/bromodomain-containing protein 4 (BRD4) inhibitor SF2523, and the bromodomain and extra terminal domain inhibitor JQ1 on the productive infection of primary macrophages with human immunodeficiency type-1 (HIV). These inhibitors did not alter the initial susceptibility of macrophages to HIV infection. However, dactolisib, JQ1, and SF2523 all decreased HIV replication in macrophages in a dose-dependent manner via degradation of intracellular HIV through autophagy. Macrophages treated with dactolisib, JQ1, or SF2523 displayed an increase in LC3B lipidation combined with SQSTM1 degradation without inducing increased cell death. LC3B-II levels were further increased in the presence of pepstatin A suggesting that these inhibitors induce autophagic flux. RNA interference for ATG5 and ATG7 and pharmacological inhibitors of autophagosome-lysosome fusion and of lysosomal hydrolases all blocked the inhibition of HIV. Thus, we demonstrate that the mechanism of PI3K/MTOR and PI3K/MTOR/BRD4 inhibitor suppression of HIV requires the formation of autophagosomes, as wel...Continue Reading

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M E KlotmanF Wong-Staal
Jul 11, 1986·Science·S GartnerM Popovic
Dec 17, 2005·Current Opinion in Oncology·Yardena Samuels, Kajsa Ericson
Sep 4, 2007·Nature Reviews. Immunology·Beth Levine, Vojo Deretic
Sep 14, 2007·The Biochemical Journal·Jenny BainPhilip Cohen
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Mar 22, 2008·AIDS·Dejiang Zhou, Stephen A Spector
Sep 12, 2008·The Journal of Biological Chemistry·Grant R Campbell, Stephen A Spector
Oct 31, 2008·Nature Reviews. Molecular Cell Biology·Guido Kroemer, Beth Levine
Mar 5, 2009·The Journal of Biological Chemistry·Ian G GanleyXuejun Jiang
Jul 29, 2009·The Journal of Cell Biology·George B KyeiVojo Deretic
Sep 28, 2010·Nature·Panagis FilippakopoulosJames E Bradner
Oct 28, 2010·AIDS Research and Human Retroviruses·Grant R CampbellStephen A Spector
Nov 11, 2010·Science Signaling·Qi-Wen FanWilliam A Weiss
Dec 24, 2010·British Journal of Clinical Pharmacology·Marco DoniaFerdinando Nicoletti
Dec 31, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yuhuan ZhengQing Yi
Feb 22, 2012·Journal of Virology·Shuzo UrataJuan Carlos de la Torre
Mar 17, 2012·Nature Reviews. Genetics·Cédric Feschotte, Clément Gilbert
Apr 5, 2012·Nature Reviews. Molecular Cell Biology·Min Sup SongPier Paolo Pandolfi
Jul 18, 2012·Journal of Leukocyte Biology·Camellia BanerjeeMonty Montano
Feb 1, 2013·Nature·Sanae Shoji-KawataBeth Levine
Feb 2, 2013·Cell Cycle·Jonathan Karn
Apr 27, 2013·Cancer Discovery·Vivian W Y LuiJennifer R Grandis
May 21, 2013·Nature Cell Biology·Ryan C RussellKun-Liang Guan

❮ Previous
Next ❯

Citations

Dec 14, 2018·Current Opinion in HIV and AIDS·Delphine PlanasPetronela Ancuta
Apr 24, 2020·Circulation Research·Patricia Cristine BorckJorge Plutzky
May 2, 2020·Cells·Burkitkan AkbaySvetlana Dokudovskaya
Dec 12, 2018·Journal of Cellular Biochemistry·Lei ZhangXiaojing Dong
Dec 4, 2019·Biological & Pharmaceutical Bulletin·Akihiro InamuraKoichi Sakurai
Jul 23, 2020·Scientific Reports·Kendra R VannTatiana G Kutateladze
Mar 11, 2020·Proceedings of the National Academy of Sciences of the United States of America·Jae-Hyun ChoPingwei Li
Oct 15, 2018·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Tiffany A Peterson, Andrew G MacLean
Aug 9, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Brittany L Allen-Petersen, Rosalie C Sears
Dec 9, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Folayemi AdefemiAaron J Marshall
Jan 27, 2021·International Journal of Molecular Sciences·Sidney IrianaNeelam Sharma-Walia
Feb 5, 2021·Journal of Medicinal Chemistry·Rinky Raghuvanshi, Sandip B Bharate
Aug 8, 2021·Cells·Grant R Campbell, Stephen A Spector
Nov 25, 2021·The Journal of International Medical Research·Xiaodong LuoXiaojing Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.